KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · Real-Time Price · USD

15.51

+0.50 (3.33%)

At close: Feb 11, 2026, 4:00 PM EST

15.54

+0.03 (0.19%)

Pre-market: Feb 12, 2026, 8:16 AM EST

KalVista Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021
Market Capitalization	784	685	479	291	312	607
Market Cap Growth	78.87%	42.97%	64.29%	-6.71%	-48.53%	211.76%
Enterprise Value	731	538	411	128	126	558
Last Close Price	15.51	13.77	11.35	8.53	12.73	24.97
PS Ratio	549.77	-	-	-	-	-
PB Ratio	19.14	7.18	2.32	1.81	1.69	2.36
P/TBV Ratio	19.22	7.18	2.32	1.81	1.69	2.36
EV/Sales Ratio	512.60	-	-	-	-	-
Debt / Equity Ratio	3.40	1.18	0.04	0.05	0.04	0.02
Asset Turnover	0.01	-	-	-	-	-
Quick Ratio	5.16	5.22	9.70	11.18	15.81	26.67
Current Ratio	5.37	5.35	9.90	11.46	16.73	27.04
Return on Equity (ROE)	-190.18%	-121.50%	-68.90%	-53.69%	-37.23%	-27.13%
Return on Assets (ROA)	-60.98%	-48.34%	-41.94%	-35.80%	-25.38%	-19.86%
Return on Capital Employed (ROCE)	-114.50%	-91.40%	-66.10%	-65.90%	-50.20%	-22.10%
Earnings Yield	-25.91%	-26.80%	-26.45%	-31.88%	-26.35%	-7.62%
FCF Yield	-21.42%	-22.40%	-18.64%	-26.23%	-25.31%	-4.98%
Buyback Yield / Dilution	-29.51%	-34.98%	-31.89%	-13.96%	-28.17%	-7.58%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q